Artiva Biotherapeutics Inc. (ARTV)
NASDAQ · Healthcare
Artiva Biotherapeutics Inc. Revenue 2023–2025
Artiva Biotherapeutics Inc. annual/quarterly revenue history and growth rate from 2023 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Artiva Biotherapeutics Inc. revenue for the quarter ending March 31, 2024 was 251000.
- Artiva Biotherapeutics Inc. annual revenue for 2025 was 0, a 100.00% decrease from 2024.
- Artiva Biotherapeutics Inc. annual revenue for 2024 was 251000, a 99.24% decrease from 2023.
- Artiva Biotherapeutics Inc. annual revenue for 2023 was 32.9 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Artiva Biotherapeutics Inc. (ARTV) — Frequently Asked Questions
Artiva Biotherapeutics Inc. (ARTV) is a publicly traded US company. It has a market capitalization of $181M. Explore ARTV's stock price, financial statements, earnings history, margins and key ratios below.
What is Artiva Biotherapeutics Inc.'s market cap?
Artiva Biotherapeutics Inc. (ARTV) has a market capitalization of $181M.
What is the ARTV stock price?
ARTV trades at $7.42 (+2.06% on the day).
Is ARTV profitable?
In fiscal 2025, Artiva Biotherapeutics Inc. reported net income of -$84M.